Stay updated with breaking news from Danielc cattran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Highlights: Continued progress has been made in advancing an investigator-initiated clinical trial to gain human proof-of-concept for Cholesterol Efflux Mediator™ VAR 200 in patients with. | May 12, 2023 ....
ZyVersa (ZVSA) Appoints Daniel C. Cattran and Fernando C. Fervenza to its Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Drs. Daniel C. Cattran and Fernando C. Fervenza join ZyVersa s distinguished group of Scientific AdvisorsVAR 200 is a phase 2a-ready cholesterol e. ....